ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Erratum for Vogelmeier et al., Eur Respir J 26 (5) 819-828.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Eur Respir J 2005; 26:1191
Copyright ©ERS Journals Ltd 2005

"BUDESONIDE/FORMOTEROL MAINTENANCE AND RELIEVER THERAPY: AN EFFECTIVE ASTHMA TREATMENT OPTION?" C. VOGELMEIER, A. D’URZO, R. PAUWELS, J.M. MERINO, M. JASPAL, S. BOUTET, I. NAYA AND D. PRICE. EUR RESPIR J 2005; 26: 819–828.

Unfortunately, in the above paper, figure 4Go was printed incorrectly and should have appeared as follows.



View larger version (14K):
[in this window]
[in a new window]
  		Fig. 4— The proportion of patients in the last 2 weeks of the study using a) low levels of as-needed medication (a maximum of 4 as-needed inhalations·week–1) or b) higher levels (>4 as-needed inhalations·week–1). Data are split by the average daily maintenance inhaled corticosteroid (ICS) dose, defined by guidelines [18] as: low or moderate dose, or high dose (for fluticasone patients only). SAL/FLU: salmeterol/fluticasone; BUD/FORM: budesonide/formoterol. : high maintenance ICS dose; {graysqu}: moderate maintenance ICS dose; {square}: low maintenance ICS dose. #: n = 688; : n = 787; +: n = 350; §: n = 247.

 
The authors have also reported a change in the Results, Overall study drug use section. The sentence "The total mean daily ICS dose in patients with high as­needed use (>4 inhalations·day–1) was: budesonide 910 µg·day–1 (BDP equivalent 1,420 µg·day–1) versus fluticasone 701 µg·day–1 (BDP equivalent 1,402µg·day–1)" should read "The total mean daily ICS dose in patients with high as­needed use (>4 inhalations·week–1) was: budesonide 910 µg·day–1 (BDP equivalent 1,420 µg·day–1) versus fluticasone 701 µg·day–1 (BDP equivalent 1,402 µg·day–1)". The authors apologise for this error.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS